Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NSE/AGARWALEYE stock hub

NSE/AGARWALEYE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/AGARWALEYEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

144.1B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/AGARWALEYE

In the news

Latest news · NSE/AGARWALEYE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E86.4

P25 24.9P50 32.4P75 45.7

Trailing P/E114.7

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC7.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/AGARWALEYE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

INR

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 150.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	INE943P01029
Last refreshed	2026-05-10
Market cap	INR 144.1B
Price	INR 454
Price currency	INR
Sector	Healthcare
Sic	8000
Symbol	nse/AGARWALEYE
Website	https://www.dragarwals.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.87%
EV Earnings	119.66x
EV/EBIT	53.13x
EV/EBITDA	27.45x
EV/Sales	7.63x
Forward P/E	86.39x
P/B ratio	7.14x
P/E ratio	114.67x
P/S ratio	7.29x
PEG ratio	2.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.37%
EBITDA Margin	23.85%
Gross margin	42.62%
Gross Profit	INR 8.4B
Gross Profit Growth	23.67%
Gross Profit Growth Q	20.94%
Net Income	INR 1.3B
Net Income Growth	40.62%
Net Income Growth Q	51.03%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	11.67%
Profit Margin	6.38%
Profitable Years	4
ROIC	7.6
Roic5y	7.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	26.15%
EPS Growth	28.48
EPS Growth Q	47.22
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	23.53x
Revenue Growth Q	23.02x
Revenue Growth Quarters	7x
Revenue Growth Years	4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 4B
Debt	INR 9.8B
Debt EBITDA	INR 1.79
Debt Equity	INR 0.49
Equity	INR 20.2B
Interest Coverage	3.07
Net Cash	INR -5.9B
Net Cash By Market Cap	INR -4.07
Net Debt EBITDA	INR 1.24
Net Debt Equity	INR 0.29
Tangible Book Value	INR 7.5B
Tangible Book Value Per Share	INR 23.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	26.13%
200-day SMA	468.8
50-day SMA	439
50-day SMA vs 200-day SMA	50under200
All Time High	568
All Time High Change	-20.16%
All Time High Date	2025-10-16
All Time Low	327
All Time Low Change	38.69%
All Time Low Date	2025-05-30
ATR	14.74
Beta1y	0.57
Beta2y	0.45
Ch YTD	-10.79
High	463
High52	568
High52 Date	2025-10-16
High52ch	-20.16%
Low	448
Low52	327
Low52 Date	2025-05-30
Low52ch	38.69%
Ma50ch	3.31%
Price vs 200-day SMA	-3.27%
RSI	56.81
RSI Monthly	57.38
RSI Weekly	49.49
Sharpe ratio	0.87x
Sortino ratio	1.49
Total Return	-9.45%
Tr YTD	-10.79
Tr1m	4.41%
Tr1w	0.21%
Tr3m	0.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.8B
Operating Income Growth	31.5
Operating Income Growth Q	33.02
Operating margin	14.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,390,754%
Shares Insiders	28.95%
Shares Institutions	11.25%
Shares Out	316,957,788
Shares Qo Q	-0.3%
Shares Yo Y	9.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	90,602.85x
Bv Per Share	61.13
Ch1m	4.41
Ch1w	0.21
Ch1y	26.13
Ch3m	0.74
Ch6m	-9.98
Change	0.89%
Change From Open	1
Close	449.5
Days Gap	-0.11
Depreciation Amortization	1,873,725,000
Dollar Volume	32,146,347.5
Earnings Date	2026-05-26
EBIT	INR 2.8B
EBITDA	INR 4.7B
EPS	INR 3.96
F Score	2
Fiscal Year End	March
Founded	2,010
Graham Number	73.84353
Graham Upside	-83.72
Income Tax	INR 698.1M
Is Primary Listing	1
Last Earnings Date	2026-02-03
Last Report Date	2025-12-31
Ma150	476.7
Ma150ch	-4.87%
Ma20	447.6
Ma20ch	1.31%
Next Earnings Date	2026-05-26
Open	449
Position In Range	36.79
Price Date	2026-05-08
Price EBITDA	INR 30.58
Ptbv Ratio	19.1
Relative Volume	0.6x
Revenue	19,760,900,000x
Tax By Revenue	3.53x
Tax Rate	30.28%
Tr6m	-9.98%
Volume	70,885

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/AGARWALEYE pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/AGARWALEYE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/AGARWALEYE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.3%

Share of float held by funds and institutions

Insider ownership

+29.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.4%

Negative means the company is buying back shares.

Technical

NSE/AGARWALEYE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.8

Neutral momentum band

Price vs 200-day MA

-3.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/AGARWALEYE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/AGARWALEYE stock rating?

nse/AGARWALEYE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/AGARWALEYE analysis?

The full report lives at /stocks/nse/AGARWALEYE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/AGARWALEYE?

The latest report frames nse/AGARWALEYE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/AGARWALEYE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.